Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
15-16
|
pubmed:dateCreated |
1990-1-25
|
pubmed:abstractText |
In treating candida vulvovaginitis attention has to be paid to the infection itself as well as to the importance of favouring conditions. With acute or non-recurring candida vulvovaginitis topical antimycotics have proved to be successful. In case of unsuccessful therapy or recurrence or chronicity the application of an intermitting topical or oral therapy is advised for an extended period of time, during or before the general symptoms, mainly premenstrually, occur. Today, an alternative to local therapy the short term application of modern oral azoles, Ketoconazole, Itraconazole, Fluconazole is suggested since no side effects are to be expected for short-time treatment. Thus adhesion-inhibitors might become a new possibility in therapy.
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0043-5341
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
31
|
pubmed:volume |
139
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
345-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading | |
pubmed:year |
1989
|
pubmed:articleTitle |
[General and advanced aspects of treatment of vulvovaginal mycosis].
|
pubmed:affiliation |
Universitätsklinik für Dermatologie und Venerologie, Graz.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract,
Review
|